This New Medicare Option Could Be a Game Changer for Seniors

Source Motley_fool

Key Points

  • Medicare now covers select GLP-1s for weight loss for qualifying beneficiaries.

  • You must have a Medicare plan that covers prescription drugs to be eligible.

  • This GLP-1 Bridge program only lasts through Dec. 31, 2027.

  • The $23,760 Social Security bonus most retirees completely overlook ›

You probably saw some living expenses drop once you retired. You likely spend less on work clothes, gas for commuting, child care, and, of course, saving for retirement. But other expenses may have risen sharply to take their place, including healthcare.

Medical expenses tend to increase as you age, regardless of how healthy you are. If you struggle with obesity, that can lead to further costly complications. But a recent Medicare change could help keep your retirement healthcare costs a bit more manageable going forward.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

A laughing couple walking off a tennis court with rackets.

Image source: Getty Images.

Medicare beneficiaries can now get GLP-1s for weight loss for $50 per month

Medicare beneficiaries have long had their GLP-1s covered for conditions like type 2 diabetes, but the program only began covering the drugs for weight loss on July 1. This is part of a new Medicare GLP-1 Bridge program that runs through Dec. 31, 2027.

Those who qualify will have a $50 copay on the following GLP-1s only:

  • Foundayo (tablet)
  • Wegovy (injection or tablet)
  • Zepbound (KwikPen only)

But not every Medicare beneficiary will qualify for this offer. You have to meet the following criteria:

  1. You must have a Medicare Part D plan or a Medicare health plan that includes drug coverage.
  2. You're not currently eligible to receive GLP-1s through your existing Medicare drug plan.
  3. You don't have type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease (your Medicare drug plan may cover GLP-1s for these conditions).
  4. You're at least 18 years of age and meet one of the following criteria:
    1. You have a body mass index (BMI) of 35 or higher.
    2. Your BMI is 30 or higher, and you have certain types of heart failure, high blood pressure that's hard to control, or chronic kidney disease (stage 3a or above).
    3. Your BMI is 27 or higher, and you have prediabetes, or you've had a heart attack, stroke, or blocked arteries in your legs or arms.

Your doctor can help you determine your BMI if you're not sure. You'll need to get a prescription from them, too.

What if you don't qualify for the $50 copay?

If Medicare's GLP-1 Bridge program isn't right for you, you can check any supplementary health insurance policies you have to see if these cover GLP-1s for weight loss. It doesn't hurt to reach out to the drug providers, too, to see if they have discounts for seniors or low-income families. You may also be able to find coupons online.

It's not clear what will happen to Medicare's GLP-1 coverage after the GLP-1 Bridge program ends. But it's possible that your Medicare plan will cover these drugs in the future, even if it doesn't today.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Intel Price Forecast: Nvidia Picked Xeon 6, Invested $5B, Yet Analysts Still Trail INTCIntel Corporation (NASDAQ: INTC) sits at $140.05, holding firm on the ascending trendline within the 2H timeframe. The RSI indicator is currently reading 55.21, positioning it as neutral-
Author  TradingKey
7 Month 02 Day Thu
Intel Corporation (NASDAQ: INTC) sits at $140.05, holding firm on the ascending trendline within the 2H timeframe. The RSI indicator is currently reading 55.21, positioning it as neutral-
placeholder
NVIDIA Price Forecast: Michael Burry Shorts NVDA, but Analysts See $299On July 1, NVIDIA (NASDAQ: NVDA) sits at $198.34, failing to break above the former support level that is now serving as resistance between $198 and $205 on the 2H chart's downward blue c
Author  TradingKey
7 Month 02 Day Thu
On July 1, NVIDIA (NASDAQ: NVDA) sits at $198.34, failing to break above the former support level that is now serving as resistance between $198 and $205 on the 2H chart's downward blue c
placeholder
Meta Compute Launch Sends AI Compute Stocks Tumbling GloballyMeta’s plan to sell surplus computing power hit chip stocks hard on Wall Street. Meta’s own shares climbed nearly 9% on the news.The announcement flipped years of assumed AI compute scarcity into a su
Author  Beincrypto
7 Month 02 Day Thu
Meta’s plan to sell surplus computing power hit chip stocks hard on Wall Street. Meta’s own shares climbed nearly 9% on the news.The announcement flipped years of assumed AI compute scarcity into a su
placeholder
Brent Crude Oil Erases Entire War Premium, Falls 40% to Pre-War LevelsBrent crude oil has erased its entire war premium, sliding roughly 40% from its March peak near $120 to trade around $72.25 on Wednesday. The move returns oil to its pre-war support base.The retreat f
Author  Beincrypto
7 Month 02 Day Thu
Brent crude oil has erased its entire war premium, sliding roughly 40% from its March peak near $120 to trade around $72.25 on Wednesday. The move returns oil to its pre-war support base.The retreat f
placeholder
Today’s Market Recap: Chip Stocks Retreat Collectively, Meta Rises Against the Trend, Non-Farm Payrolls Become the Next Key CatalystOn July 1, Eastern Time, U.S. stocks closed fluctuating lower on the first trading day of the second half of the year. Although some megacap tech stocks such as Meta (
Author  TradingKey
7 Month 02 Day Thu
On July 1, Eastern Time, U.S. stocks closed fluctuating lower on the first trading day of the second half of the year. Although some megacap tech stocks such as Meta (
goTop
quote